Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema

Khalil J. Diab, Jeremy J. Adamowicz, Krzysztof Kamocki, Natalia I. Rush, Jana Garrison, Yuan Gu, Kelly S. Schweitzer, Anastasia Skobeleva, Raja Shekhar Gangaraju, Walter C. Hubbard, Evgeny V. Berdyshev, Irina Petrache

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine-S1P-S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography-tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor-induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P-S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.

Original languageEnglish (US)
Pages (from-to)344-352
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume181
Issue number4
DOIs
StatePublished - Feb 15 2010

Fingerprint

Alveolar Epithelial Cells
Emphysema
Ceramides
Cell Survival
Vascular Endothelial Growth Factor Receptor
Sphingosine
Lysosphingolipid Receptors
Lung
Apoptosis
Sphingolipids
DNA Nucleotidylexotransferase
sphingosine 1-phosphate
Tandem Mass Spectrometry
Immunoblotting
Liquid Chromatography
Caspase 3
Endothelial Cells
Epithelial Cells
RNA

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. / Diab, Khalil J.; Adamowicz, Jeremy J.; Kamocki, Krzysztof; Rush, Natalia I.; Garrison, Jana; Gu, Yuan; Schweitzer, Kelly S.; Skobeleva, Anastasia; Gangaraju, Raja Shekhar; Hubbard, Walter C.; Berdyshev, Evgeny V.; Petrache, Irina.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 181, No. 4, 15.02.2010, p. 344-352.

Research output: Contribution to journalArticle

Diab, KJ, Adamowicz, JJ, Kamocki, K, Rush, NI, Garrison, J, Gu, Y, Schweitzer, KS, Skobeleva, A, Gangaraju, RS, Hubbard, WC, Berdyshev, EV & Petrache, I 2010, 'Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema', American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 4, pp. 344-352. https://doi.org/10.1164/rccm.200906-0826OC
Diab, Khalil J. ; Adamowicz, Jeremy J. ; Kamocki, Krzysztof ; Rush, Natalia I. ; Garrison, Jana ; Gu, Yuan ; Schweitzer, Kelly S. ; Skobeleva, Anastasia ; Gangaraju, Raja Shekhar ; Hubbard, Walter C. ; Berdyshev, Evgeny V. ; Petrache, Irina. / Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. In: American Journal of Respiratory and Critical Care Medicine. 2010 ; Vol. 181, No. 4. pp. 344-352.
@article{75969ce241234b45848c6d30d4a175e5,
title = "Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema",
abstract = "Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine-S1P-S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography-tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor-induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P-S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.",
author = "Diab, {Khalil J.} and Adamowicz, {Jeremy J.} and Krzysztof Kamocki and Rush, {Natalia I.} and Jana Garrison and Yuan Gu and Schweitzer, {Kelly S.} and Anastasia Skobeleva and Gangaraju, {Raja Shekhar} and Hubbard, {Walter C.} and Berdyshev, {Evgeny V.} and Irina Petrache",
year = "2010",
month = "2",
day = "15",
doi = "10.1164/rccm.200906-0826OC",
language = "English (US)",
volume = "181",
pages = "344--352",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema

AU - Diab, Khalil J.

AU - Adamowicz, Jeremy J.

AU - Kamocki, Krzysztof

AU - Rush, Natalia I.

AU - Garrison, Jana

AU - Gu, Yuan

AU - Schweitzer, Kelly S.

AU - Skobeleva, Anastasia

AU - Gangaraju, Raja Shekhar

AU - Hubbard, Walter C.

AU - Berdyshev, Evgeny V.

AU - Petrache, Irina

PY - 2010/2/15

Y1 - 2010/2/15

N2 - Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine-S1P-S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography-tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor-induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P-S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.

AB - Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine-S1P-S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography-tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor-induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P-S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.

UR - http://www.scopus.com/inward/record.url?scp=76149139431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149139431&partnerID=8YFLogxK

U2 - 10.1164/rccm.200906-0826OC

DO - 10.1164/rccm.200906-0826OC

M3 - Article

VL - 181

SP - 344

EP - 352

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -